spiperone has been researched along with Ophthalmoplegia, Progressive Supranuclear in 1 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pierot, L | 1 |
| Desnos, C | 1 |
| Blin, J | 1 |
| Raisman, R | 1 |
| Scherman, D | 1 |
| Javoy-Agid, F | 1 |
| Ruberg, M | 1 |
| Agid, Y | 1 |
1 other study available for spiperone and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Topics: Adenylyl Cyclases; Adult; Aged; Benzazepines; Caudate Nucleus; Dopamine Antagonists; Humans; Middle | 1988 |